This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Peter Garabedian
Senior Director, US NPP, Neuroscience, Rare Disease and PDT at Takeda
Speaker

Profile

Peter is a Senior Director at Takeda Pharmaceuticals. He leads a team responsible for therapeutic and disease strategy, new product planning for development programs and conducts business development assessments for Neuroscience, Rare Disease and Plasma Derived Therapies franchises. Peter has over 25 years of pharmaceutical commercial experience. He has held positions of increasing responsibility in commercial development, U.S. and global marketing roles in rare diseases, hematology, cardiology and transplantation.

Agenda Sessions

  • Engineering Value – Crafting BD Strategies that Win in Rare Disease

    9:45am